WestRock Company announced that D. Michael Wilson will be the CEO of the company’s specialty chemicals business that is expected to become a publicly traded company, Ingevity, early next year as a result of a spin-off from WestRock. He will join the company on September 1, 2015.
“Michael Wilson brings breadth and depth of specialty chemicals experience to Ingevity,” said Steve Voorhees, CEO of WestRock.
Wilson comes to Ingevity from Albemarle Corporation, where he most recently served as EVP leading Albemarle’s Performance Chemicals business. Prior to that, He led Albemarle’s Catalyst Solutions business and held a variety of business unit leadership roles at FMC, Wausau Papers and Rexam.